Alcidion Appoint Resapp Health co-founder, Brian Leedman as Non-Executive Director (ASX:$ALC)

Nathan Buzza

Company Name: Alcidion

Announcement Date: 02/08/2016
Announcement Category: Team Update
Announcement Content:

Adelaide, South Australia, 28th July 2016 – Alcidion Group Limited (ASX: ALC), a global leader in Clinical Informatics, today announced the appointment of Mr. Brian Leedman to the board of the Company. This move comes at a pivotal time for Alcidion as the company looks to expand market share of their award-winning Miya Platform product internationally.

Mr. Leedman is the co-founder of Resapp Health (ASX:RAP) where he currently serves in the role of Executive Director and Vice President, Corporate Affairs. Mr. Leedman is a marketing and investor relations professional with over 10 years’ experience in the biotechnology / healthcare industry. Prior to Resapp Health, Mr. Leedman co-founded Enigma Therapeutics which listed on the ASX in 2013 as Oncosil Medical Limited.

Mr. Leedman previously served for 10 years as Vice President, Investor Relations for pSivida Corp. which is listed on the ASX and NASDAQ. He is currently the Western Australian Co-Chair of AusBiotech, the association of biotechnology companies in Australia.

"Clinical Informatics is a rapidly growing market that's critical to improve productivity, safety and efficiency across the continuum of health. Alcidion has demonstrated clear technology leadership over other players in the space and I'm excited about helping to guide the company to a broader role in the market. I believe this is the right company, at the right time, in the right market," said Mr. Leedman.

"With the drive for cost control and the new mandates surrounding EMRAM regulations, Alcidion has an ideal solution," said Mr. Leedman. "I'm looking forward to helping Alcidion expand on their track record of delivering significant improvements to patient flow."

The appointment coincides with major technical and market advancements for Alcidion, with the company recently announcing enhanced features for its award-winning Miya Platform. The new version, extends the product's architecture to support Physician Order Entry and Smartforms - features key to increasing clinician productivity and mitigating clinical risk.

‘Alcidion’s focus is on empowering clinicians to deliver the highest quality patient care” said Nathan Buzza, Executive Director of Alcidion. "Brian’s significant experience in bringing new medical technologies into the mainstream will be very important to us as we begin our next phase of growth.

Ray Blight, Chairman of Alcidion Group Limited commented, “It is my pleasure to welcome Brian to the Board of Alcidion. I’m certain through his wealth of experience and passion for the sector, he will be a valuable addition to the Board”.


Announcement URL: http://www.asx.com.au/asxpdf/20160728/pdf/438vxg7vzjqy3w.pdf
About Alcidion:

Alcidion provides intelligent Health Informatics technology that empowers healthcare professionals with Clinical Decision Support Systems to ensure the highest quality of care for their patients.

Go to Company Profile for: Alcidion

Announcement Contact: [email protected]

Nathan Buzza

Having founded Clinical Middleware provider CommtechWireless in 1992, Nathan grew this business into a successful multinational with offices in Perth, Sydney, Jacksonville, Hong Kong, Shenzhen, Vejle & London deploying the technology across 8000 locations worldwide. With 25 years’ experience in software, electronics and medical technology, Nathan is recognised as a technology pioneer in the evolution and implementation of specialised medical technology. In 2008 Nathan negotiated the trade sale of CommtechWireless to Amcom Software and continued as GM for 18 months post acquisition. Prior to the acquisition, Buzza was the principal shareholder, CEO and Chief Technologist of the company and was responsible for strategic planning, technology development and administration of the company’s affairs. In 2010, Amcom Software was acquired by USA Mobility (now Spok) for $163.8m. The business was listed by BRW as one of the fastest growing privately held companies in Australia for three consecutive years and the recipient of numerous accolades including: The Telstra Small Business of the Year Award, The Department of Industry & Resources “CY O’Conner Award for Excellence in Engineering” as well as the ATUG “Best Communication Solution”. In 2006, Nathan’s accomplishments were recognised by Ernst & Young, where Nathan was awarded the “Entrepreneur of the Year” as well as the WA IT & Telecommunications Life Time achievement Award for contribution to the IT community. Nathan judged the Innovator of the Year Awards and the Curtin and Cambridge Universities Ignite Programmes in 2010. Prior to Alcidion, Nathan’s Private Equity firms were the second largest shareholder of Azure Healthcare (ASX:AZV) and during Nathan’s tenure, the company share price increased 1200%. Nathan is a member of the NiQ Healthcare Advisory Board and a General Partner in Private Equity Firm, Future Health. Nathan studied a Bachelor of Commerce at Curtin University, majoring in IT.

Leave a Reply